Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DNA Methylation Changes in Melasma Treatment
NCT03392623Phase 1Completed
- Sponsor
- Universidad Autónoma de San Luis Potosí
- Start
- Jan 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of nicotinamide, tretinoin and Sunscreen Sport Lotion (BAY987516) in melasma (4 arms), sponsored by Universidad Autónoma de San Luis Potosí. Primary endpoint: Improve in the level of DNA methylated at 8 weeks. Started Jan 2015; status: completed.
02
Drugs
nicotinamidetretinoinSunscreen Sport Lotion (BAY987516)
03
Conditions
melasma
Beyond the preview
Go deeper on NCT03392623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03392623.